NCT07698886 — "Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel" trial site landscape

Public-registry site landscape for NCT07698886, “Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel”, a HPV (Human Papillomavirus)-Associated study sponsored by KTH Biopharma. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07698886 (registry record)
Study title	Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel
Sponsor	KTH Biopharma
Condition(s)	HPV (Human Papillomavirus)-Associated; Genital Warts
Phase	PHASE2
Listed sites	1
Intervention(s)	Geniwa gel
Site countries	Vietnam

Patient-friendly overview of this study: eichor.com/study/NCT07698886.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07698886 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →